Cargando…
Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy
Genome editing holds great potential for cancer treatment due to the ability to precisely inactivate or repair cancer-related genes. However, delivery of CRISPR/Cas to solid tumors for efficient cancer therapy remains challenging. Here, we targeted tumor tissue mechanics via a multiplexed dendrimer...
Autores principales: | Zhang, Di, Wang, Guoxun, Yu, Xueliang, Wei, Tuo, Farbiak, Lukas, Johnson, Lindsay T., Taylor, Alan Mark, Xu, Jiazhu, Hong, Yi, Zhu, Hao, Siegwart, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931497/ https://www.ncbi.nlm.nih.gov/pubmed/35551240 http://dx.doi.org/10.1038/s41565-022-01122-3 |
Ejemplares similares
-
Membrane destabilizing ionizable phospholipids for organ selective mRNA delivery and CRISPR/Cas gene editing
por: Liu, Shuai, et al.
Publicado: (2021) -
Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing
por: Cheng, Qiang, et al.
Publicado: (2020) -
Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration †
por: Yu, Xueliang, et al.
Publicado: (2021) -
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
por: Wei, Tuo, et al.
Publicado: (2020) -
Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)